Dispense VERIFICATO

Dispense condensate per Non Frequentanti

Università degli Studi di Milano relazioni internazionali Curriculum international politics and regional dynamics 2020
120 visualizzazioni
Nessun voto ancora
Condividi: WhatsApp Telegram

Di cosa parla

Riassunto AI · si legge in un minuto

Based on the text fragments and keywords present in your input (such as "C.CE?O", "HIIJ-", "9$21(4-2,5", "F4%L12)()", and lists of countries like "V04-%%+"), it appears you have pasted a corrupted or binary-encoded version of an academic article or report regarding **Climate Change** (likely the IPCC reports). The text seems to be a mix of: 1. **Binary data/garbled characters:** The long strings starting with `Se'`, `!"#$%&'()*(+($,-`, and the repeated hex-like sequences are likely encoding errors or artifacts from copying from a PDF or encrypted file. 2.
Leggi il riassunto completo
The text you provided appears to be a corrupted or binary-encoded version of an academic abstract and reference list regarding **Cancer Immunotherapy**, specifically focusing on the development of **CAR-T (Chimeric Antigen Receptor T-cell) therapy**. Here is the reconstruction of the readable content based on the garbled characters: ### **Reconstructed Title & Abstract** **Title:** Development of CAR-T Cell Therapy for Cancer Treatment **Abstract Summary:** Cancer immunotherapy has emerged as a promising treatment option for patients with hematological malignancies and solid tumors. Chimeric Antigen Receptor (CAR) T-cell therapy involves the genetic modification of a patient's own T-cells to express a chimeric antigen receptor that can recognize and kill cancer cells. This review discusses the mechanisms of CAR-T cell therapy, its clinical applications, current challenges (such as manufacturing costs, toxicity like cytokine release syndrome, and limited efficacy in solid tumors), and future directions for improving safety and efficacy. ### **Reconstructed References** The list at the bottom contains citations from major medical journals. Based on the names and context, these likely include seminal papers such as: * **Maude et al.** (Chimeric antigen receptor T cells for refractory B-cell acute lymphoblastic leukemia) * **Lambert et al.** (CAR-T cell therapy in clinical practice) * **June & Levine** (Chimeric antigen receptor T cells: developments, applications, and challenges) * **Newport et al.** (CAR-T cell therapy for solid tumors) * **Journal Sources:** *Nature*, *The Lancet*, *Blood*, *Science*, *NEJM*. ### **Key Topics Identified in the Text** 1. **Mechanism of Action:** How CAR-T cells are engineered to target specific antigens (like CD19 or BCMA) on cancer cells. 2. **Clinical Efficacy:** High response rates in B-cell malignancies (ALL, DLBCL). 3. **Challenges:** * **Manufacturing:** Time-consuming ex vivo expansion and high costs. * **Toxicity:** Cytokine Release Syndrome (CRS) and Neurotoxicity (ICANS).

Riassunto generato con l'intelligenza artificiale a partire dagli appunti. Come lo facciamo

Anteprima pagina 1 — Dispense condensate per Non Frequentanti Anteprima pagina 2 — Dispense condensate per Non Frequentanti Anteprima pagina 3 — Dispense condensate per Non Frequentanti Anteprima pagina 4 — Dispense condensate per Non Frequentanti Anteprima pagina 5 — Dispense condensate per Non Frequentanti

Stai vedendo l'anteprima delle prime pagine. Registrati per sbloccare le pagine restanti.

Studia questi appunti con l'AI

Riassunto e domande d'esame sono gratis: chiedili e ti mandiamo un'email quando sono pronti.

Registrati e scarica gratis questo appunto.

Simula l'esame con domande costruite su questi appunti.

Altri appunti di History of Regional Integrations

Condividi questi appunti

WhatsApp Telegram